Aromasin
Links shared publicly online about this topic
Aromasin cuts risk of breast cancer in some groups
health.yahoo.net — “The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on Saturday.” View full resource at health.yahoo.net
Most Recently Shared on June 4, 2011 at 7:20 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
Aromasin cuts risk of breast cancer in some groups: The estrogen-blocker Aromasin was found to reduce the risk o... http://bit.ly/iBtOzx
Aromasin cuts risk of breast cancer in some groups
health.yahoo.net — “The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on Saturday.” View full resource at health.yahoo.net
Most Recently Shared on June 4, 2011 at 7:22 pm By:
Jane Anderson Healthy Eating Advisor
Aromasin cuts risk of breast cancer in some groups http://bit.ly/lEEXsV
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women
health.yahoo.net — “SATURDAY, June 4 (HealthDay News) -- The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found.” View full resource at health.yahoo.net
Most Recently Shared on June 6, 2011 at 4:27 am By:
Jane Anderson Healthy Eating Advisor
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women http://bit.ly/lRQuoZ
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women
health.yahoo.net — “SATURDAY, June 4 (HealthDay News) -- The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found.” View full resource at health.yahoo.net
Most Recently Shared on June 5, 2011 at 6:42 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women: SATURDAY, June 4 (HealthDay News) -- The anti-estro... http://bit.ly/mqZ2sM
Aromasin cuts risk of breast cancer in some groups | Reuters
reuters.com — “CHICAGO (Reuters) - The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on Saturday.A” View full resource at reuters.com
Most Recently Shared on June 4, 2011 at 3:53 pm By:
Aromasin cuts risk of breast cancer in some groups: CHICAGO (Reuters) - Pfizer Inc's breast cancer drug Aromasin... http://bit.ly/jW0nw2
Aromasin cuts risk of breast cancer in some groups | Reuters
reuters.com — “CHICAGO (Reuters) - The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on Saturday.A” View full resource at reuters.com
Most Recently Shared on June 4, 2011 at 4:11 pm By:
HealthIT Policy Health IT and Health News
Aromasin cuts risk of breast cancer in some groups: CHICAGO (Reuters) - Pfizer Inc's breast cancer drug Aromasin... http://bit.ly/myJ50z
Aromasin cuts risk of breast cancer in some groups | Reuters
reuters.com — “CHICAGO (Reuters) - The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on Saturday.A” View full resource at reuters.com
Most Recently Shared on June 4, 2011 at 3:56 pm By:
Aromasin cuts risk of breast cancer in some groups http://reut.rs/mL5Q0w
Aromasin cuts risk of breast cancer in some groups | Reuters
reuters.com — “CHICAGO (Reuters) - The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on Saturday.A” View full resource at reuters.com
Most Recently Shared on June 4, 2011 at 7:30 pm By:
Hisham Rana, MD Doctor and Physician
News: Aromasin cuts risk of breast #cancer in some groups http://reut.rs/iT7pgK - #health
Novartis’s Afinitor helps Pfizer’s Aromasin to Delay Breast Cancer | The Haystack
cenblog.org — “Looks like Afinitor (everolimus), a drug marketed by Novartis for various cancers, may soon have a new indication. Already approved for a variety of diseases – kidney cancer, pancreatic tumors, and organ rejection prevention – Afinitor shows new promise for breast cancer patients. Clinical data released Monday demonstrate marked improvement for hormone-resistant breast cancer patients [...]” View full resource at cenblog.org
Most Recently Shared on September 28, 2011 at 2:23 pm By:
When Afinitor, an mTOR inhibitor, is used in combination with the aromatase inhibitor Aromasin, good things happen http://t.co/CPulkAU5
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - Drugs.com MedNews
drugs.com — “The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found. And unlike oth” View full resource at drugs.com
Most Recently Shared on June 6, 2011 at 1:32 am By:
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - http://bit.ly/j8vbsn
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - Drugs.com MedNews
drugs.com — “The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found. And unlike oth” View full resource at drugs.com
Most Recently Shared on June 4, 2011 at 7:05 pm By:
Drugs and Devices OW OW Health
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women: SATURDAY, June 4 -- The anti-estrogen drug Ar... http://bit.ly/je4qVi #drug
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - MSN Health - Breast Cancer
health.msn.com — “But at least one cancer expert says more research is needed” View full resource at health.msn.com
Most Recently Shared on June 4, 2011 at 9:25 pm By:
Bruce McLucas, MD ObGyn Physician, Surgeon, Physician, and Doctor
Aromasin Reduced Breast Cancer Risk in Postmenopausal Women http://ow.ly/1d3lGD
Survival Benefit Maintained In Long Term Follow-up Of IES With Pfizer's AROMASIN(R) (Exemestane Tablets)
medicalnewstoday.com — “Pfizer Inc announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three ” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2009 at 12:47 pm By:
MNT Women's Health Health News
Survival Benefit Maintained In Long Term Follow-up Of IES With Pfizer's AROMASIN(R) (Exemestane Tablets): Pfizer.. http://bit.ly/xGumL
Aromasin (exemestane) Reduces Breast Cancer Risk In Postmenopausal Women, Study - QualityPoint Technologies
qualitypointtech.net — “Exemestane (Aromasin), an aromatase inhibitor, was found to lower invasive breast cancer rates by 65% in moderate and high-risk postmenopausal females, researchers at the Massachusetts General Hospital Cancer Center in Boston reported. An aromatase inhibitor inhibits aromatase, an enzyme involved in the production of estrogen estradiol. Many breast cancers are promoted by estrogens. After the menopause, most estrogen comes from the action of aromatase. Aromatase inhibitors can be very effective ” View full resource at qualitypointtech.net
Most Recently Shared on June 4, 2011 at 8:45 pm By:
Aromasin (exemestane) Reduces Breast Cancer Risk In Postmenopausal Women, Study: Exemestane (Aromasin), an aromata... http://bit.ly/k4JrWI
Susan G. Komen for the Cure | Aromasin Reduces Breast Cancer Risk in High-risk Women
ww5.komen.org — “Susan G. Komen for the Cure | Aromasin Reduces Breast Cancer Risk in High-risk Women” View full resource at ww5.komen.org
Most Recently Shared on June 7, 2011 at 5:50 pm By:
Komen for the Cure Health Organization
Interesting article from @komenforthecure about reducing breast cancer risk in high-risk women. http://bit.ly/ldU4nB #breastcancerrisk
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Jennifer Ann Grisso
Jennifer, RN,BSN Business Minded RN, Over 20 years as an RN in most areas.Chicagoan !Great sense of humor. Learning and studying HIT. Sold Medical Supplies and Devices. Nursing experience in most areas, more in Cardiac.
-
Jane Anderson
-
Jane Anderson
Advertisement
